Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice

  1. Álamo, M.C.
  2. Ochenduszko, S.
  3. Crespo, G.
  4. Corral, M.
  5. Oramas, J.
  6. Sancho, P.
  7. Medina, J.
  8. Garicano, F.
  9. López, P.
  10. Balea, B.C.
  11. Garzotto, A.R.
  12. Muñoz-Couselo, E.
Aldizkaria:
OncoTargets and Therapy

ISSN: 1178-6930

Argitalpen urtea: 2021

Alea: 14

Orrialdeak: 5345-5352

Mota: Artikulua

DOI: 10.2147/OTT.S325208 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus